The Cellular Immunotherapy for Cancer Working Committee provides scientific oversight for studies related to the utilization and outcomes after CAR-T Cell therapies and other cellular immunotherapies. Studies that focus on specific outcomes, a predictor of outcomes, and utilization of CAR-T Cells should be submitted to this committee.
Cameron Turtle
University of Sydney
Sydney NSW,
Christine Phillips
Cincinnati Children's Hospital Medical Center
Cincinnati, OH
Sairah Ahmed
M.D. Anderson Cancer Center
Houston, TX
Soyoung Kim
CIBMTR - Milwaukee
Milwaukee, WI
Amy Moskop
Matthew Bye